
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded capsule containing pyridoxal 5-phosphate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing pyridoxal phosphate is listed. Products containing it are filed in the directory as unapproved drugs, in capsule and tablet forms, all of them multi-ingredient vitamin products.
This is a solid, nonaqueous dose form. Under USP <795>, nonaqueous preparations carry longer default beyond-use dates than water-containing ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Pyridoxal 5-phosphate is the active coenzyme form of vitamin B6; no FDA-approved drug product exists, and pharmacies may compound it on prescription.
Pyridoxal 5-phosphate (PLP, also written P5P) is the active coenzyme form of vitamin B6. Each form of vitamin B6 taken in food or supplements can be converted by the body to PLP. It helps more than 100 enzyme reactions, mostly in protein and amino acid metabolism, and is involved in making brain chemical messengers (neurotransmitters). No FDA-approved drug product contains PLP: an openFDA Drugs@FDA search found no match, and DailyMed lists PLP only as one ingredient in multi-ingredient dietary supplements, medical foods and unapproved drug products. Some vitamin supplements contain PLP. A prescriber might order PLP compounded as a single-ingredient preparation in a strength or form chosen for the patient. Compounded preparations are not FDA-approved and require a prescription.
There is no FDA drug label for PLP, so these points come from NIH and StatPearls sources on vitamin B6. Long-term high intake of vitamin B6 can cause sensory nerve damage, with numbness, tingling and trouble with coordination; tell your prescriber right away if these occur. Some seizure medicines (valproic acid, carbamazepine, phenytoin) and theophylline are linked to low PLP levels, and isoniazid can lead to vitamin B6 deficiency (StatPearls). Tell your prescriber about every medicine and supplement you take. If you are pregnant, talk with your prescriber first; NIH notes that doses used for nausea and vomiting in pregnancy can approach the upper intake limit. LactMed notes that B6 is naturally present in breast milk, that maternal supplements raise milk levels, and that higher maternal intakes are not expected to expose breastfed infants to a harmful amount. For other side effects, talk to your prescriber or pharmacist.
PLP is the coenzyme for transamination, decarboxylation, racemization and elimination reactions (StatPearls) and supports the biosynthesis of neurotransmitters (NIH ODS). Vitamin B6 vitamers are absorbed in the jejunum, and each can be enzymatically converted to PLP; plasma PLP is the main measure of B6 status (NIH ODS). Pyridoxine has a short plasma half-life and is inactivated in the liver to 4-pyridoxic acid, which is excreted in urine (StatPearls). There is no labeled indication and no FDA-approved PLP drug product. FDA's list of bulk drug substances nominated for 503A compounding (updated May 14, 2026) places pyridoxal 5-phosphate monohydrate in Category 1, bulk substances under evaluation. StatPearls describes vitamin B6 dependency syndromes, inborn errors of PLP-dependent enzymes, and PLP-responsive metabolic disorders; use of PLP for any condition is not an FDA-approved indication. Dosing is per prescriber; NIH notes that the Food and Nutrition Board upper limit does not apply to people receiving vitamin B6 for medical treatment. Monitor for sensory neuropathy (paresthesias, ataxia), which StatPearls identifies as the classic B6 toxicity, and review concurrent anticonvulsants, theophylline, isoniazid and cycloserine.
Swallow each capsule whole with a glass of water, unless your label says otherwise. Do not crush, chew or open the capsule unless your pharmacist tells you it is safe to do so. Take it at the times shown on your prescription label. If you miss a dose or are unsure how to take it, call the pharmacy.
Capsules are nonaqueous, so under USP <795> they usually carry a beyond-use date of up to 180 days when no other stability data apply. Keep the vial tightly closed at room temperature, away from heat, moisture and direct light, and out of reach of children. Discard any capsules left after the beyond-use date on the label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth